BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 22405057)

  • 1. Computational insights into the inhibition of inosine 5'-monophosphate dehydrogenase by mycophenolic acid analogs: three-dimensional quantitative structure-activity relationship and molecular docking studies.
    Yang N; Wang J; Wang ZW; Wang QH; Yang HG; Wang XJ; Cheng MS
    Chem Biol Drug Des; 2012 Jun; 79(6):1063-71. PubMed ID: 22405057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A three-dimensional pharmacophore model for IMPDH inhibitors.
    Yang N; Wang J; Li J; Wang QH; Wang Y; Cheng MS
    Chem Biol Drug Des; 2011 Jul; 78(1):175-82. PubMed ID: 21507206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycophenolic acid analogs with a modified metabolic profile.
    Chen L; Wilson DJ; Labello NP; Jayaram HN; Pankiewicz KW
    Bioorg Med Chem; 2008 Oct; 16(20):9340-5. PubMed ID: 18809333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping the binding site of a large set of quinazoline type EGF-R inhibitors using molecular field analyses and molecular docking studies.
    Hou T; Zhu L; Chen L; Xu X
    J Chem Inf Comput Sci; 2003; 43(1):273-87. PubMed ID: 12546563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploration of a binding mode of indole amide analogues as potent histone deacetylase inhibitors and 3D-QSAR analyses.
    Guo Y; Xiao J; Guo Z; Chu F; Cheng Y; Wu S
    Bioorg Med Chem; 2005 Sep; 13(18):5424-34. PubMed ID: 15963726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3D-QSAR studies of Checkpoint Kinase Weel inhibitors based on molecular docking, CoMFA and CoMSIA.
    Yi P; Fang X; Qiu M
    Eur J Med Chem; 2008 May; 43(5):925-38. PubMed ID: 17698256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3D QSAR studies on protein tyrosine phosphatase 1B inhibitors: comparison of the quality and predictivity among 3D QSAR models obtained from different conformer-based alignments.
    Pandey G; Saxena AK
    J Chem Inf Model; 2006; 46(6):2579-90. PubMed ID: 17125198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docking-based 3D-QSAR study for 11beta-HSD1 inhibitors.
    Lee JH; Kang NS; Yoo SE
    Bioorg Med Chem Lett; 2008 Apr; 18(7):2479-90. PubMed ID: 18314331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3D-QSAR and molecular docking studies of 2-pyrimidinecarbonitrile derivatives as inhibitors against falcipain-3.
    Potshangbam AM; Tanneeru K; Reddy BM; Guruprasad L
    Bioorg Med Chem Lett; 2011 Dec; 21(23):7219-23. PubMed ID: 22018459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3D-QSAR studies of boron-containing dipeptides as proteasome inhibitors with CoMFA and CoMSIA methods.
    Zhu YQ; Lei M; Lu AJ; Zhao X; Yin XJ; Gao QZ
    Eur J Med Chem; 2009 Apr; 44(4):1486-99. PubMed ID: 18771818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3D-QSAR studies of JNK1 inhibitors utilizing various alignment methods.
    Madhavan T; Chung JY; Kothandan G; Gadhe CG; Cho SJ
    Chem Biol Drug Des; 2012 Jan; 79(1):53-67. PubMed ID: 21722320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A combined approach of docking and 3D QSAR study of beta-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors.
    Ashek A; Cho SJ
    Bioorg Med Chem; 2006 Mar; 14(5):1474-82. PubMed ID: 16275103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of type 1 inosine monophosphate dehydrogenase as an antiangiogenic drug target.
    Chong CR; Qian DZ; Pan F; Wei Y; Pili R; Sullivan DJ; Liu JO
    J Med Chem; 2006 May; 49(9):2677-80. PubMed ID: 16640327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined 3D-QSAR modeling and molecular docking study on indolinone derivatives as inhibitors of 3-phosphoinositide-dependent protein kinase-1.
    AbdulHameed MD; Hamza A; Liu J; Zhan CG
    J Chem Inf Model; 2008 Sep; 48(9):1760-72. PubMed ID: 18717540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3D-QSAR studies on tripeptide aldehyde inhibitors of proteasome using CoMFA and CoMSIA methods.
    Zhu YQ; Pei JF; Liu ZM; Lai LH; Cui JR; Li RT
    Bioorg Med Chem; 2006 Mar; 14(5):1483-96. PubMed ID: 16256351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inosine monophosphate dehydrogenase (IMPDH) as a target in drug discovery.
    Shu Q; Nair V
    Med Res Rev; 2008 Mar; 28(2):219-32. PubMed ID: 17480004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3D-QSAR studies on triazolopiperazine amide inhibitors of dipeptidyl peptidase-IV as anti-diabetic agents.
    Saqib U; Siddiqi MI
    SAR QSAR Environ Res; 2009 Jul; 20(5-6):519-35. PubMed ID: 19916112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of the inosine 5'-monophosphate dehydrogenase (IMPDH) inhibitors.
    Cholewiński G; Iwaszkiewicz-Grześ D; Prejs M; Głowacka A; Dzierzbicka K
    J Enzyme Inhib Med Chem; 2015; 30(4):550-63. PubMed ID: 25198892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3D-QSAR and molecular docking studies of 1,3,5-triazene-2,4-diamine derivatives against r-RNA: novel bacterial translation inhibitors.
    Sekhar YN; Nayana MR; Sivakumari N; Ravikumar M; Mahmood SK
    J Mol Graph Model; 2008 Jun; 26(8):1338-52. PubMed ID: 18372201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational studies of COX-2 inhibitors: 3D-QSAR and docking.
    Kim HJ; Chae CH; Yi KY; Park KL; Yoo SE
    Bioorg Med Chem; 2004 Apr; 12(7):1629-41. PubMed ID: 15028256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.